Anebulo Pharmaceuticals I...

NASDAQ: ANEB · Real-Time Price · USD
2.51
0.07 (2.87%)
At close: Aug 15, 2025, 3:59 PM
2.50
-0.40%
After-hours: Aug 15, 2025, 04:10 PM EDT

Anebulo Pharmaceuticals Balance Sheet Statement

Financials in USD. Fiscal year is July - June.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Jun 30, 2024 Jun 30, 2023 Jun 30, 2022 Jun 30, 2021
Cash & Equivalents
3.09M 11.25M 14.55M 19.99M
Short-Term Investments
n/a n/a n/a n/a
Long-Term Investments
n/a n/a n/a n/a
Other Long-Term Assets
565.12K n/a n/a n/a
Receivables
n/a n/a n/a n/a
Inventory
n/a n/a n/a n/a
Other Current Assets
n/a n/a n/a n/a
Total Current Assets
3.51M 11.25M 14.55M 19.99M
Property-Plant & Equipment
n/a n/a n/a n/a
Goodwill & Intangibles
n/a n/a n/a n/a
Total Long-Term Assets
565.12K n/a 1.03M 1.67M
Total Assets
4.07M 11.67M 15.58M 21.65M
Account Payables
156.43K 534.54K 380.83K 110.05K
Deferred Revenue
n/a n/a n/a n/a
Short-Term Debt
n/a n/a n/a n/a
Other Current Liabilities
n/a n/a n/a n/a
Total Current Liabilities
260.58K 534.54K 512.53K 241.63K
Long-Term Debt
n/a n/a n/a n/a
Other Long-Term Liabilities
n/a n/a n/a n/a
Total Long-Term Liabilities
0.00 534.26K 380.83K 131.59K
Total Liabilities
260.58K 1.07M 512.53K 241.63K
Total Debt
n/a n/a n/a n/a
Common Stock
25.93K 25.63K 23.34K 23.34K
Retained Earnings
-65.4M -57.2M -45.47M -38.64M
Comprehensive Income
n/a 0.00 n/a -21.65M
Shareholders Equity
3.81M 10.6M 15.07M 21.41M
Total Investments
n/a n/a n/a n/a